Research on methylation of HPA-axis genes has suggested that altered methylation levels of the FKBP5 gene may have potential as a biomarker of depression [17, 18], however, results concerning methylation levels of the FKBP5 gene in depressive symptoms are inconsistent. The gene discussed is FKBP5; the disease is depressive disorder.